Cord Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsCytomegalovirus InfectionsRoseolovirus InfectionsTransplantation, AutologousAspergillosisHistocompatibility TestingStem CellsCytomegalovirusTreatment OutcomeFetal BloodBone Marrow TransplantationRetrospective StudiesTissue DonorsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraHematopoietic Stem CellsGraft SurvivalGraft vs Leukemia EffectBusulfanRecurrenceImmunosuppressive AgentsMyeloablative AgonistsRemission InductionLeukemiaVidarabineGraft vs Tumor EffectImmunocompromised HostHistocompatibilityTransplantationWhole-Body IrradiationLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMultiple MyelomaTime FactorsT-LymphocytesCombined Modality TherapyEmbryonic Stem CellsLymphocyte DepletionSpinal CordAntigens, CD34Salvage TherapyOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoietic Stem Cell MobilizationSurvival AnalysisAdult Stem CellsVirus ActivationSiblingsMycosesSurvival RateAnemia, AplasticMyelodysplastic SyndromesAcute DiseaseHepatic Veno-Occlusive DiseaseHematologic DiseasesChimerismCell DifferentiationMinor Histocompatibility AntigensGraft RejectionLymphocyte TransfusionAntilymphocyte SerumImmunosuppressionHerpesvirus 6, HumanCells, CulturedPluripotent Stem CellsHLA AntigensBlood Transfusion, AutologousDisease-Free SurvivalGanciclovirAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryCyclophosphamideLeukocyte TransfusionFollow-Up StudiesMelphalanNeoplasm, ResidualSpinal Cord InjuriesFatal OutcomeTransplantation ImmunologyAntiviral AgentsBone Marrow CellsLymphoproliferative DisordersKidney TransplantationCyclosporineStem Cell NicheMesenchymal Stem Cell TransplantationPyrimidinesPrognosisLeukemia, MyeloidInduced Pluripotent Stem CellsCell SeparationMesenchymal Stromal CellsGranulocyte Colony-Stimulating FactorAntineoplastic Agents